Researchers have identified a cell cycle-regulated mechanism behind the transformation of normal cells into cancerous cells. The study results suggest that inhibition of the CK1 enzyme may be a new therapeutic target for the treatment of cancer cells formed as a result of a malfunction in the cell’s mTOR signaling pathway.